NASDAQ:CERT

Certara (CERT) Stock Price, News & Analysis

Certara logo
$10.55 -0.13 (-1.22%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$10.58 +0.03 (+0.32%)
As of 11/20/2026 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Certara Stock (NASDAQ:CERT)

Advanced

Key Stats

Today's Range
$10.42
▼
$10.86
50-Day Range
$8.00
▼
$12.22
52-Week Range
$4.45
▼
$12.61
Volume
2.78 million shs
Average Volume
2.76 million shs
Market Capitalization
$1.61 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.91
Consensus Rating
Hold

Company Overview

Certara provides software and consulting services that support the development and use of medicines. Its biosimulation tools help pharmaceutical and biotechnology companies model how drugs behave in the body, assess potential treatment outcomes, and inform decisions during drug research and development.

The company’s offerings include software for pharmacokinetic and pharmacodynamic modeling, clinical trial simulation, and drug development analysis. Certara also provides scientific and regulatory consulting, including support for regulatory submissions and strategies that use modeling and simulation to guide development programs.

Based in Princeton, New Jersey, Certara serves pharmaceutical and biotechnology companies, regulatory agencies, and other organizations involved in life sciences around the world. Its business combines proprietary software with scientific expertise to help customers evaluate medicines and navigate development and regulatory processes.

AI Generated. May Contain Errors.

Certara Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

CERT MarketRank™: 
1.507146860985 of 5 stars

Certara scored higher than 30% of companies evaluated by MarketBeat, and ranked 729th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Certara has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 4 buy ratings, 7 hold ratings, and 1 sell rating.

  • Downside Risk

    Certara has a consensus price target of $9.91, representing about 6.1% downside from its current price of $10.55.

  • Amount of Analyst Coverage

    Certara has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Certara's stock forecast and price target.
  • Earnings Growth

    Earnings for Certara are expected to grow by 40.00% in the coming year, from $0.20 to $0.28 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Certara is -25.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Certara is -25.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Certara has a P/B Ratio of 1.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    16.92% of the float of Certara has been sold short.
  • Short Interest Ratio / Days to Cover

    Certara has a short interest ratio ("days to cover") of 11.55, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Certara has recently decreased by 0.59%, indicating that investor sentiment is improving.
  • Dividend Yield

    Certara does not currently pay a dividend.

  • Dividend Growth

    Certara does not have a long track record of dividend growth.

  • News Sentiment

    Certara has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Certara this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for CERT on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Certara to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Certara insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    1.08% of the stock of Certara is held by insiders.

  • Percentage Held by Institutions

    73.96% of the stock of Certara is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Certara's insider trading history.
Receive CERT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Certara and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CERT Stock News Headlines

Certara (CERT) Stock May Be Near Fair Value After A 63% Slump
Certara, Inc. (NASDAQ:CERT) Stock Has Average Price Target of $9.92
Your $7 scanner is waiting
The Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.tc pixel
Certara, Inc. (CERT) Q3 2026 Earnings Call Transcript
UBS Downgrades Certara to Neutral From Buy, Price Target is $13
Why Did Certara (CERT) Shares Climb After Its Latest Update?
See More Headlines

CERT Stock Analysis - Frequently Asked Questions

Certara's stock was trading at $8.81 on January 1st, 2026. Since then, CERT shares have increased by 19.8% and is now trading at $10.55.

Certara, Inc. (NASDAQ:CERT) released its quarterly earnings results on Thursday, November, 5th. The company reported $0.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.00. The company's quarterly revenue was down 9.3% on a year-over-year basis.
Read the conference call transcript
.

Certara (CERT) raised $685 million in an initial public offering (IPO) on Wednesday, December 9th 2020. The company issued 33,413,250 shares at a price of $19.00-$22.00 per share. Jefferies, Morgan Stanley, BofA Securities, Credit Suisse, Barclays and William Blair acted as the underwriters for the IPO.

Top institutional investors of Certara include State Street Corp (3.10%), Royce & Associates LP (1.93%), Boston Partners (1.51%) and Goldman Sachs Group Inc. (1.11%). Insiders that own company stock include Richard M Traynor, Leif E Pedersen and Patrick F Smith.
View institutional ownership trends
.

Shares of CERT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Certara investors own include NVIDIA (NVDA), ASML (ASML), Energy Transfer (ET), Palantir Technologies (PLTR), Super Micro Computer (SMCI), SoundHound AI (SOUN) and Tesla (TSLA).

Company Calendar

Last Earnings
11/05/2026
Today
11/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NASDAQ:CERT
CIK
1827090
Fax
N/A
Employees
1,576
Year Founded
2008

Price Target and Rating

High Price Target
$13.00
Low Price Target
$6.00
Potential Upside/Downside
-6.1%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.42)
Trailing P/E Ratio
N/A
Forward P/E Ratio
37.68
P/E Growth
N/A
Net Income
-$1.60 million
Net Margins
-16.14%
Pretax Margin
-3.25%
Return on Equity
3.36%
Return on Assets
2.31%

Debt

Debt-to-Equity Ratio
0.29
Current Ratio
2.58
Quick Ratio
2.58

Sales & Book Value

Annual Sales
$425.76 million
Price / Sales
3.78
Cash Flow
$0.76 per share
Price / Cash Flow
13.94
Book Value
$6.41 per share
Price / Book
1.65

Miscellaneous

Outstanding Shares
152,543,000
Free Float
150,896,000
Market Cap
$1.61 billion
Optionable
Optionable
Beta
1.30

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:CERT) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners